Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Novel ACAT inhibitors disclosed by Pierre Fabre Medicament

Nov. 7, 2012

Progress of EXC-001 triggers payment to Isis Pharmaceuticals

Nov. 6, 2012

New modulators of the expression of aquaporin-3 patented by Lipotec

Oct. 31, 2012

Derma Sciences to begin phase III DSC-127 program

Oct. 23, 2012

Preliminary phase II findings for MABP-1 in psoriasis

Oct. 18, 2012

Idera Pharmaceuticals completes patient enrollment in phase II IMO-3100 trial

Oct. 16, 2012

Enrollment continues in Can-Fite BioPharma's phase II/III psoriasis study

Oct. 11, 2012

Taisho Pharmaceutical presents new agents for alopecia

Oct. 10, 2012

Revance Therapeutics regains worldwide rights to botulinum toxin products

Oct. 9, 2012

DVS-603 improves psoriasis symptoms

Oct. 8, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...